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SUMMARY
Dopaminergic neurons in the substantia nigra (SNc) innervate both striatum and the superior colliculus in mammals, as well as its homolog the optic tectum in lampreys, belonging to the oldest group of living vertebrates [1] [2] [3] . In the lamprey, we have previously shown that the same neuron sends axonal branches to both striatum and the optic tectum [3] . Here, we show that most neurons in the lamprey SNc and ventral tegmental area (VTA) (also referred to as the nucleus of the posterior tuberculum) express not only tyrosine hydroxylase (TH), in lamprey a marker of dopaminergic neurons [4] , but also the vesicular glutamate transporter (vGluT), suggesting that glutamate is a co-transmitter. Remarkably, the axonal branches that project to striatum elicit both dopaminergic and glutamatergic synaptic effects on striatal neurons, whereas the axonal projections to the optic tectum only evoke dopaminergic effects. Thus, axonal branches from the same neuron can use two transmitters in one branch and only one in the other. Previous studies suggest that, along an individual dopaminergic axon, there can be microdomains of either TH or vGluT [5] [6] [7] [8] . In addition, the present results demonstrate that entire axonal branches to one target structure can differ from that of branches to another target, both originating from the same dopamine neuron. This implies that a given dopamine neuron can exert different effects on two different target structures. The combined release of dopamine and glutamate may be appropriate in striatum, whereas the effects exerted on the tectal motor center may be better served with a selective dopaminergic modulation.
RESULTS AND DISCUSSION
Characterization of SNc/VTA Neurons Dopaminergic neurons in the substantia nigra pars compacta and ventral tegmental area (SNc/VTA) are critical for operation of the basal ganglia [9] . The role of dopamine in the striatum is well conserved through vertebrate evolution, and SNc/VTA modulates the excitability of striatal neurons in a similar way in both lampreys (oldest living vertebrates) and mammals [1, 10, 11] . GABA and glutamate are also co-expressed with dopamine in the mammalian SNc/VTA [12] . To characterize the neurotransmitter phenotype present in the lamprey SNc/VTA, its limits were first delineated. The lamprey homolog of the SNc/VTA, the nucleus of the posterior tuberculum, is located in the caudal diencephalon (Figure 1A) and contains dopaminergic neurons ( Figure 1B ) that target striatum [13] . These striatum-projecting neurons send collaterals to brainstem motor-related centers, including the optic tectum and mesencephalic locomotor region (MLR) [1, 3, 14, 15] . The SNc/VTA can be clearly differentiated from the cerebrospinal fluid-contacting (CSF-c) dopaminergic neurons in the mammillary area, which are significantly smaller (8.9 ± 1.2 mm, n = 240; versus 13.0 ± 2.8 mm, n = 182 in SNc/VTA; Student's t test, p < 0.01; Figure 1B) , and neither project to striatum nor to tectum. Thus, only the more dorsal dopaminergic neurons were considered as part of the SNc/VTA (see Figure 1F ). A differentiation between SNc and VTA has not yet been established in the lamprey, because no segregation between the dorsal and ventral striatum could be demonstrated [1, 16] . Dopaminergic neurons in the lamprey SNc/VTA represent a population of around 600 cells ( Figure 1C ; N = 3) compared to the estimation of all brain neurons (0.1% of 5.9 3 10 5 ). A comparably low percentage is also observed for mammals, despite the much larger absolute numbers [17, 18] .
Most Dopaminergic SNc/VTA Neurons Co-express Glutamate
The high degree of homology between the lamprey and the mammalian SNc/VTA [1] suggests that the same neurotransmitter phenotypes [12] are present also in the lamprey. To analyze this, we performed in situ hybridization for vesicular glutamate transporter (vGluT) and glutamic acid decarboxylase (GAD), combined with tyrosine hydroxylase (TH) immunohistochemistry. vGluT is an accepted marker for glutamatergic neurons [19] , whereas glutamate immunohistochemistry can be less sensitive. TH/vGluT (Figure 1D) and TH/GAD ( Figure 1E ) co-expressing neurons were found, as well as vGluT/GAD and TH/vGluT/GAD phenotypes (not shown). Thus, the same neuronal phenotypes are present in lamprey, zebrafish [20] , and mammals [21] [22] [23] [24] . [22, 24, 25] , the lamprey SNc/VTA is more homogeneous and no obvious regional differences exist (Figure 1F) . In mammals, SNc and VTA show differences in their vGluT/TH ratio and TH/vGluT co-expressing neurons-higher in the VTA than in the SNc [21] [22] [23] [24] . Although several factors can affect this estimation (e.g., detection method and threshold), the lamprey SNc/VTA shows a high vGluT-to-TH ratio and a high co-expression of vGluT and dopamine (Figures 1F and  1G; Table 1 ). Previous studies did not find co-localization of dopamine and glutamate or GABA [26, 27] , most likely due to low sensitivity of the used methods. However, a recent study indicated co-expression of glutamate and dopamine in lamprey SNc/VTA neurons [28] .
Many SNc/VTA Neurons Project to Both the Striatum and Optic Tectum and Express Glutamate
The high percentage of dopaminergic neurons that co-express vGluT raises the question of whether SNc/VTA neurons corelease dopamine and glutamate. We also analyzed whether these two neurotransmitters are differentially released in different brain areas targeted by the same SNc/VTA neurons, given that release sites are segregated in micro-domains within the rodent striatum [7] . We analyzed the co-expression in neurons targeting the striatum and tectum, which both receive inputs from the same individual neurons in the SNc/VTA [3] . First, we investigated whether a glutamatergic input from the SNc/VTA to tectum and striatum is present, as suggested by the large number of dopaminergic neurons expressing vGluT. Tracer injections combined with in situ hybridization for vGluT showed that most neurons that project to tectum express vGluT (Figure 2D; 79% ± 2.1%; N = 3), and the same is observed after striatal injections ( Figure 2E ; 85% ± 1.5%; N = 2). Tract tracing (Figure 2A) combined with immunohistochemistry for TH and in situ hybridization for vGluT and GAD confirmed that a subpopulation of dopaminergic SNc/VTA cells projects to tectum ( Figure 2B ) and that the majority of these dopaminergic neurons co-express vGluT, but not GAD ( Figure 2F ). Most of the neurons that project to tectum also send an axonal branch to the striatum ( Figure 2C ; 71% ± 5.7%; N = 3). Moreover, most of these cells express vGluT (82% ± 3.8%; N = 3) and, only in few cases, GAD (Figures 2D, 2F, and S1B; tectum-projecting neurons vGluT = 9, GAD = 2, vGluT+GAD = 1, unknown = 4; tectum and striatum-projecting neurons: vGluT = 32, GAD = 3, vGluT+GAD = 2, unknown = 8; N = 1). Our results suggest that most of the dopaminergic SNc/VTA neurons targeting tectum also send collaterals to striatum and co-localize glutamate, but not GABA. This was confirmed by combining tracer injections into the striatum and tectum with vGluT in situ hybridization and TH immunohistochemistry ( Figure S1C ; n = 2).
Fibers Co-expressing Dopamine and Glutamate Are Found in Striatum, but Not in Optic Tectum
We next examined whether TH/vGluT-immunopositive terminals from the SNc/VTA are present in the striatum and tectum. Tracer injections into the SNc/VTA ( Figure 3A ) combined with immunohistochemistry for vGluT and TH showed that many TH/vGluT fibers originating from the SNc/VTA are present in the striatum (see also [26] ; Figure 3B , arrowheads; N = 3). These results suggest that, as in mammals [7] , dopamine and glutamate may be co-released in the striatum. Unexpectedly, no TH/vGluT fibers were observed in tectum, although many TH fibers, anterogradely labeled from the SNc/VTA, were detected ( Figure 3C ; N = 3), as well as vGluT fibers that were not anterogradely labeled. This lack of TH/vGluT fibers in tectum suggests that only dopamine is released from the SNc/VTA terminals in this region.
Dopaminergic SNc/VTA Neurons Differentially Influence Striatum and Optic Tectum
The anatomical results suggested that individual neurons can co-release glutamate and dopamine in striatum, whereas only dopamine is released in tectum. Expressing detectable levels of the neurotransmitter, transporter, or the enzymes that synthesize transmitters does not always mean that the neurons release the neurotransmitter [29, 30] . We therefore performed extracellular recordings to test whether SNc/VTA stimulation gives rise not only to dopaminergic but also to glutamatergic effects in the striatum and whether both glutamatergic and dopaminergic or merely dopaminergic effects are elicited in tectum. Using the experimental preparation in Figure 3D (middle), single-pulse stimulation was applied to the SNc/VTA ( Figure 3A ; N = 5). This induced activity in striatum with short latency ( Figure 3D , left), which was blocked by glutamatergic antagonists (not shown; see, however, below Figures S2G and S2F), whereas no responses were detected in tectum ( Figure 3D , right). These results suggest that glutamate is released in striatum in response to SNc/VTA activation, whereas it is not released in tectum or has only subthreshold effects (N = 5). Although glutamatergic effects may be easily detected using extracellular recordings, this is not the case for the modulatory effects elicited by dopamine. We have, however, recently shown that dopamine from the SNc/ VTA has strong modulatory effects on the excitability of tectal neurons [3] . SNc: human 0.02 0.29 0.00 5.90 [22] VTA: rat 0.40 2.50 4.00 64.00 [19] VTA: mouse 0.40 67.00 0.00 27.00 [21] VTA: human 0.11 1.70 0.50 31.50 [22] SNc/VTA: lamprey 1 2.82 15.03 83.00 96.00 this paper, Figure 1F SNc/VTA: lamprey 2 2.54 46.25 73.00 100.00 this paper, not shown
Note that minimum (min.) and maximum (max.) ranges are given across multiple sub-regions and/or across multiple animals, except for the lamprey, where the minimum and maximum ranges are given across multiple sub-regions for individual animals.
To confirm that dopaminergic, but not glutamatergic, effects are evoked in tectum by SNc/VTA stimulation, we used a preparation maintaining the SNc/VTA and exposing tectal cells ( Figure 3H , top) to perform whole-cell patch-clamp recordings of tectal neurons and to analyze the effects of electrically stimulating the SNc/VTA. Holding output tectal neurons in current clamp at À65 mV (reversal potential for inhibition) [31, 32] , 10 Hz stimulation (8 pulses plus recovery; n = 15) did not result in excitatory postsynaptic potentials (EPSPs) ( Figure 3E , red trace). We also recorded tectal neurons at more depolarized levels (À40 to À45 mV; close to spike threshold) to test the possibility of GABAergic effects (10 Hz; 8 pulses plus recovery). No inhibitory postsynaptic potentials (IPSPs) were evoked by SNc/ VTA stimulation ( Figure 3E , blue trace), as expected from the anatomical results showing that dopaminergic neurons that project to tectum do not co-express GABA ( Figures 2C and 2F ). To confirm that the lack of responses was not due to ineffective stimulation, we performed (n = 8) a tetanic stimulation of the SNc/VTA (10 Hz; 10 s) to evoke a long-lasting release of dopamine (see [3] ), which clearly affected the excitability of tectal neurons. Spikes were evoked in tectal output neurons after a depolarizing current injection under control conditions ( Figure 3F , black trace). After the tetanic stimulation, the number of elicited spikes was strongly reduced for the same current step ( Figure 3F , green trace; see also Figure 3G ). The stimulation intensities capable of evoking dopaminergic effects never evoked EPSPs. These results show that dopamine from the SNc/VTA modulates tectal excitability, without evidence of glutamate or GABA corelease. The lack of EPSPs in response to SNc/VTA stimulation and that no TH/vGluT fibers were detected in tectum strongly suggest that the SNc/VTA effects in this region are purely dopaminergic, despite many tectum-projecting neurons co-expressing vGluT/TH.
In contrast to tectum, both dopaminergic and glutamatergic effects were observed in individual striatal neurons upon SNc/ VTA stimulation. To perform patch-clamp recordings of striatal neurons while stimulating SNc/VTA, we used a thick-slice preparation ( Figure 3H , bottom). EPSPs were evoked in striatal neurons held above À84 mV (reversal potential for inhibition) [33] after SNc/VTA stimulation ( Figure 3I , red trace; n = 35). In most neurons, no inhibitory responses were evoked ( Figure 3I , blue trace), whereas in a subset of striatal neurons, IPSPs were elicited when holding neurons at more depolarized levels ( Figure S2A ; n = 7). We also performed a tetanic stimulation (n = 16) that elicited inhibitory (Figures 3J and 3K; n = 7) or excitatory (Figures S2B and S2C; n = 9) modulatory dopaminergic effects. Because Figures 3I-3K show data from the same neuron, it can be concluded that SNc/VTA stimulation leads to dopaminergic and glutamatergic effects in the same individual neurons in striatum. To demonstrate that the glutamatergic inputs are monosynaptic and that dopamine and glutamate are co-released from the same SNc/VTA neuron, we verified that (1) EPSP latencies (13-33 ms) are within a predicted range for monosynaptic responses mediated by dopaminergic neurons (12-35 ms; see STAR Methods), (2) EPSPs to repeated stimulations show constant latencies, and (3) EPSP responses persist despite bath application of a high divalent ion Ringer solution (Ca 2+ 4 mM; Mg 2+ 8 mM; Figure S2D ), which suppresses polysynaptic transmission [31, 34] . Figures S2B and S2C show a striatal neuron that underwent enhanced excitability after SNc/VTA tetanic stimulation and whose evoked EPSPs ( Figure S2D , top trace) persist after application of high Mg 2+ /Ca 2+ solution ( Figure S2D , bottom trace).
To confirm that the evoked EPSPs were glutamatergic, both 100 mM APV (NMDA component) and 80 mM CNQX (AMPA component) were administered, which removed the evoked EPSPs (Figures S2E and S2F; n = 3). To exclude the involvement of glutamate in the excitability changes, we tested whether the effects of SNc/VTA tetanic stimulation on excitability persisted during glutamate receptor block (n = 2). Figure S2G shows a striatal neuron that undergoes an increase in excitability after SNc/VTA tetanic stimulation. After recovery, glutamate receptors were blocked (Figures S2E and S2F) and SNc/VTA was stimulated, giving rise again to an increase in excitability (see Figure S2H ). These results additionally support that the excitability changes are mediated by dopamine and are not an indirect effect of glutamate transmission. To show the dopaminergic nature of the effects observed, we let a few neurons recover after the tetanic stimulation (n = 3) and subsequently applied either a D1 or D2 receptor agonist (SKF 81297 for D1, n = 2; and quinpirole for D2, n = 1), depending on whether excitability had been enhanced or decreased, respectively. Agonists evoked the same effects as tetanic stimulation. The graph in Figure S2I shows the number of evoked action potentials after a ramp of increasing depolarizing current steps (black). SNc/VTA (B and C) In striatum (B), axons show co-labeling of Neurobiotin, TH-, and vGluT-immunoreactivity, whereas in tectum (C), many axons were co-labeled with Neurobiotin and TH, but not vGluT. Scale bars represent 10 mm (B) and 25 mm (C). (D) Extracellular recordings in striatum and tectum of the isolated whole-brain preparation during electrical stimulation of SNc/VTA show direct responses in striatum (left trace), but not in tectum (right trace). (E-G) Example of whole-cell recordings of a tectal neuron: (E) no excitatory (bottom; neuron held at À65 mV) nor inhibitory (top; neuron held at À40 mV, close to spike threshold) PSPs were evoked in response to 10-Hz SNc stimulation. Artifacts were removed to improve readability. (F) The lack of responses was not due to ineffective stimulation, since the same cell underwent a strong reduction in the number of evoked APs for the same depolarizing current injections after performing a tetanic stimulation of the SNc/VTA (control trace in black, and green trace shows the response after SNc/VTA stimulation). (I) Excitatory (bottom; neuron held at À80 mV), but not inhibitory (top; neuron held at À50 mV) PSPs were evoked in a striatal neuron in response to SNc/VTA stimulation. Double lines indicate truncated spikes. Inhibitory responses, the effects of blocking polysynaptic transmission, and the effects of blocking glutamate receptors are shown in Figure S2 . (J) SNc/VTA tetanic stimulation led to a modulatory dopaminergic effect, decreasing the number of evoked spikes for the same depolarizing current injection (black trace for control, green trace after tetanic stimulation, and yellow trace for recovery). See Figure S2 for excitatory modulatory dopaminergic effects. Changes in excitability persisted after blocking glutamate transmission, and the same effects were observed after application of dopamine receptor agonists (see Figure S2 ). (K) The number of evoked APs for a series of depolarizing current injections is plotted in control conditions (black), after SNc/VTA tetanic stimulation (green), and after $10 min recovery. (L) Summarizing schematic. Dopaminergic neurons co-expressing glutamate project to both striatum and tectum and dopamine modulates both regions, whereas glutamate effects are only observed in the striatum. In (G) and (K) *p < 0.05 and ***p < 0.001 (paired t test). stimulation gives rise to an increase in the number of elicited action potentials (green). After recovery (yellow), D1 agonist application results again in a larger number of evoked action potentials (red). Representative traces are shown in Figure S2J .
Altogether, these results suggest that glutamate release in SNc/VTA neurons co-expressing TH/vGluT is restricted to striatum, whereas the SNc/VTA innervation of tectum is devoid of glutamatergic signaling ( Figure 3L ). There is some precedency for having axonal branches of a neuron exerting different effects on target cells. For example, in the stomatogastric system, a modulatory neuron is reported to act by proctolin in one branch and GABA in the other [35] , and in motoneurons (mouse), the intraspinal recurrent collaterals release both acetylcholine and glutamate, although at the neuromuscular junction, the action is through acetylcholine [36, 37] . However, glutamate-like immunoreactivity has been reported [38] in the motoneuronal terminals innervating skeletal muscles. Taken together, it would seem likely that differential dual transmission is present in motoneurons, but results are not fully conclusive.
Conclusions
Our results show that co-expression of vGluT and TH, markers of glutamate and dopamine, in SNc/VTA neurons was present early in vertebrate evolution, supporting previous results from the lamprey [28] . Different neurotransmitter phenotypes exist in the lamprey SNc/VTA, although most TH-positive neurons co-express vGluT. This includes the individual dopaminergic SNc/VTA neurons that project to both the striatum and tectum. Remarkably, only striatal SNc/VTA axons exhibit co-localization of dopamine and glutamate, whereas SNc/VTA axons in tectum are only dopaminergic. Consequently, upon SNc/VTA stimulation, dopaminergic effects were observed in both striatum and tectum, whereas glutamatergic effects were only observed in striatum. Altogether, our results show that individual SNc/ VTA dopaminergic neurons can release different neurotransmitters in different axonal branches. Thus, the ability to spatially segregate neurotransmitter release is not restricted to microdomains in the striatum, but SNc/VTA neurons can also differentially influence diverse brain areas. The co-release of glutamate and dopamine may be advantageous in the striatum, whereas glutamate action could possibly disturb the processing in tectum, a motor center that directly controls eye and orienting movements. In the case of tectum, the exclusive dopamine modulation [3] may be more appropriate. Interestingly, dopaminergic cells in the SNc send collaterals to striatum and MLR [14] and both glutamate and dopaminergic effects are evoked [28] . The dopaminergic system shows a very high degree of conservation through vertebrate evolution, and it is therefore likely that similar mechanisms of differential neurotransmitter release may be present in mammals.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Experiments were performed on a total of 44 adult river lampreys (Lampetra fluviatilis) of either sex in the anadromous stage. Animals were kept at 4 C with a 12 h/12 h light/dark cycle. Animal housing and maintenance was licensed by the office for environment and consumer protection of the city of Cologne, Germany. The experimental procedures were approved by the federal ministry for nature, environment and consumer protection of Nordrhine-Westfalia, Germany, and the local ethics committee in Stockholm (Northern Stockholm Animal Review Board), Sweden, and were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (1996 revision). Every effort was made to minimize animal suffering and to reduce the number of animals used during the study.
METHOD DETAILS Dissection
Lampreys were anesthetized with MS-222 (ethyl 3-minobenzoate methanesulfonate; 100 mg/L water; Sigma, St. Louis, MO) dissolved in water from the aquarium at 4 C. Animals were then decapitated with a scalpel caudal to the gills and moved to a preparation tray on ice (containing Sylgard gel; Dow Corning, Midland, MI) filled with 4 C artificial cerebral spinal fluid (aCSF), with the following composition (in mM): NaCl 125, KCl 2.6, MgCl 2 1, CaCl 2 2, NaHCO 3 25, glucose 10. The brain was then exposed and removed or left in situ for the tracing experiments.
mRNA Isolation, cDNA Synthesis and in situ Hybridization Probes After removal, the brains (N = 2) was immediately put in RNALater (Sigma-Aldrich). Total mRNA was extracted using the easy-spin Total RNA Extraction Kit (iNtRON Biotechnology) resulting in highly concentrated mRNA (OD 260 > 0.9 as measured by Nanodrop photometer). cDNA was synthesized from the mRNA by using the SuperScript II Reverse Transcriptase (Invitrogen). Sense and antisense probes with the T7 promoter for in situ hybridization were produced as follows: For vGluT two previously published primer-pairs were used [39]: 1. FW 5 0 -TTACTGCCGCTGCCAAATC-3 0 and REV 5 0 -TAACG CTTGGGCATTCCG-3 0 , product length 584bp, also spanning the non-coding UTR region and 2. FW 5 0 -TGCCCATCGGAGGA CAAC-3 0 and REV 5 0 -CTCGTCCTCGTTGATGAAG-3 0 , product length 483bp, exclusively located in the coding region. These primers were originally developed based on a cDNA brain library of Lampetra fluviatilis and tested in Petromyzon marinus.
For GAD, primer-pairs were designed from multiple sequence alignment of available GAD sequences of most related species (Lethenteron camtschaticum [shotgun sequence KE993764.1], Petromyzon marinus [AF432157], Ichtyomyzon unicuspis [AF432158] and Myxine glutinosa [AF432156], see Figure S4 ). One primer based on the Lethenteron camtschaticum genome led to good results (s.b.): FW 5 0 -CCCGTGTTCGTCCTCATGGA-3 0 and REV 5 0 -CCGTTGAGCTTGTGGCGATG-3 0 , product length 518bp.
The quality of all probes was verified by gel electrophoresis and the correct probe sequences validated by sequencing. Probe sequences were deposited in GenBank, and the accession numbers are Genbank: MH818802 for vGluT and Genbank: MH818803 for GAD.
Tract Tracing
After exposure, the brain was either bilaterally injected with 50-100 nL Neurobiotin (20% w/v; Vector Labs; SP-1120) in the optic tectum (N = 3), striatum (N = 2), or the SNc/VTA (N = 3). For dual labeling, Neurobiotin was injected bilaterally in the striatum and tetramethylrhodamine (TMR) conjugated dextran amine (20% w/v; 3 kD, Life Technology) was injected bilaterally in the optic tectum (N = 3). The preparation was subsequently kept submerged in aCSF at 4 C in the dark for 16-24 h to allow transport of the tracer(s). aCSF was exchanged every 8 h.
Fixation and Cryosectioning
Immediately after removal, the brains were fixed by immersion in 4% freshly prepared paraformaldehyde (PFA) in 0.01 M phosphate buffered saline (PBS) pH 7.4 for 17-24 h at 4 C. Subsequently, brains were cryoprotected in 20% sucrose in DEPC treated PBS pH 7.4 for 3 h at 4 C, embedded (Sakura Tissue Tek O.C.T. Compound), and frozen through immersion in liquid nitrogen. Brains were either directly sectioned or kept at À80 C until further processing. 20 mm transverse sections were prepared on a Leica CM 3050 S cryostat and mounted on Menzel Superfrost Plus slides in adjacent series. Sections were left at 37 C for 2-3 h before proceeding with in situ hybridization and immunohistochemistry.
In situ Hybridization Combined with Immunohistochemistry
For in situ hybridization and combined immunohistochemistry 5 animals were used. In situ hybridization for both vGluT antisense probes and for one GAD antisense probe showed strong staining. Specificity was verified by parallel test of corresponding sense probes on adjacent slice series, which did not yield any staining (see Figure S3 for unpublished GAD sense and antisense riboprobes). In situ hybridization was performed as follows: The sections were washed in PBS (pH 7.5) for 5 min, permeabilized in 2x standard saline citrate (SSC) in DEPC treated water for 25 min, treated with 0.1% H 2 O 2 in PBS for 10 min, washed twice in PBS for 5 min, acetylated in 0.25 acetic anhydride in 0.1 M triethanolamine (pH 8), and washed in PBS for 5 min. Subsequently, sections were hybridized overnight at 60 C with digoxigenin (DIG) or Fluorescein (Flu) labeled vGluT and/or GAD probes, diluted to a final concentration of 3-5ng/mL in a solution of 50% deionized formamide (pH 5), 5x SSC, 0.15 mg/mL heparin, 5 mg/mL torula-RNA; 0.1% Tween 20 and 1x Denhardt's solution. After hybridization, the slides were rinsed briefly in 5x SSC; 30 min in 50% formamide in 2x SSC; 30 min in 2x SSC and 30 min in 0.2 SSC at 65 C. After two additional washes in 0.2xSSC (15 min) and PBS (5 min), the sections were blocked in TNB (0.1 M Tris-HCl pH 7.5; 150 mM NaCl; 0.5% blocking reagent) for 60 min.
Both chromatogenic in situ hybridization detection with NBT/BCIP (N = 8; Roche Diagnostics), and fluorescent in situ hybridization (FISH) with the tyramide signal amplification (TSA) method (N = 6) [40, 41] yielded comparable results for both Flu and DIG labeled vGluT and GAD riboprobes (not all combinations shown). Either vGluT and GAD (N = 2) or only vGluT (N = 6) labeling were combined with tract tracing experiments. In situ hybridization was combined with immunohistochemistry for TH (N = 5) as follows.
Sections were incubated overnight at 4 C in alkaline phosphatase labeled sheep anti-DIG antibody (1:300; Roche Diagnostics; RRID_AB_514497) in TNB. They were then then washed 3x in TNT-buffer (Tris-HCl pH 7.5; 150 mM NaCl; 0.05% Tween 20) and 2x in detection buffer (100 mM Tris-HCl pH 9.5; 150 mM NaCl) for 10 min. The alkaline phosphatase was visualized using NBT/ BCIP (Roche Diagnostics) in detection buffer. After the reaction was stopped by washing in PBS for 5 min and in H 2 O for 2 min, the sections were rinsed 3x in TNT-buffer for 10 min. Afterward the sections were incubated with a rabbit anti-TH polyclonal antibody (AB152; Merck Millipore; 1:200; RRID_AB_390204) in TNB at 4 C overnight. Following 3x10 min washes in TNT-buffer, sections were incubated with Cy3 conjugated goat anti-rabbit IgG (1:500; Jackson ImmunoResearch; RRID_AB_2338000), 4',6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich, 200 mg/L) and for the combined tract tracing experiments Neurobiotin was visualized with streptavidin-Alexa 633 (1:300; Thermo Fisher; Cat #S21375) in TNB for 2 h.
For vGluT mRNA FISH combined with TH immunohistochemistry (N = 4), bound riboprobes were visualized with peroxidase-conjugated anti-DIG antibody (1:300; Roche Diagnostics; RRID_AB_514500) and TH with the rabbit anti-TH antibody (AB152; Merck Millipore; 1:200; RRID_AB_390204) in TNB at 4 C overnight. After 3 washes in TNT-buffer for 10 min each, sections were incubated with Cy3 conjugated goat anti-rabbit IgG (1:500; Jackson ImmunoResearch; RRID_AB_2338000), 4',6-diamidino-2-phenylindole (DAPI, 200 mg/L) and for the combined tract tracing experiments with streptavidin-Alexa 633 (1:300; Thermo Fisher; Cat #S21375) in TNB for 2 h. Following 3 additional washes in TNT-buffer for 5 min, sections were incubated with biotylinated-tyramides (experiments without tract tracing using Neurobiotin as tracer) or DIG-tyramides (tract tracing experiments using Neurobiotin) in TSA buffer (PBS pH 7.5; 0.1M imidazole; 0.001% H2O2) for 10 min. The sections were washed 3x in TNT-Buffer, incubated with Alexa 488-(1:500; Jackson ImmunoResearch; Cat #016-540-084) or Alexa 633-(1:300; Thermo Fisher; Cat #S21375) conjugated streptavidin (non-tract tracing experiments) or with mouse anti-DIG-488 (tract tracing experiments; 1:300; Jackson ImmunoResearch; RRID_AB_2339039) in TNB for 1 h, and washed 3x15 min in TNT-buffer.
vGluT mRNA in situ hybridization and GAD mRNA FISH detection combined with TH immunohistochemistry (N = 1): NBT/BCIP detection of vGlutT was immediately followed by FISH-TSA for GAD detection combined with TH immunohistochemistry (see above for details).
Finally, sections were coverslipped with glycerol containing 2.5% DABCO (Sigma-Aldrich; D27802) and stored at À20 C.
Combined TH and vGluT immunohistochemistry
Brains (N = 3) were injected bilaterally in SNc/VTA with Neurobiotin. After incubation in aCSF, fixation and cryosectioning (30 mm, one brain transversally and two brains sagittally), drying at 37 C for 2 h and rehydration in PBS for 10 min, heat induced epitope retrieval was performed in sodium citrate pH 8 at 80 C for 15 min and then cooled under running tap water for 5 min followed by 2 washes in PBS for 15 min each. Subsequently, slices were incubated in a mixture of rabbit anti-vGluT (1:100; Abcam; RRID_AB_2187677) and chick anti-TH (1:1000; Abcam; RRID_AB_1524535) antibodies in 1% BSA, 0.3% Triton-X in 0.1 M PB pH 7.4 for 24 h at 4 C. Following 3 washes in PBS for 15 min, sections were incubated with goat anti-chick Dylight 650 (1:500; Abcam; RRID_AB_10681018), goat antirabbit Cy3 (1:500; RRID_AB_2338000), streptavidin-Alexa 488 (1:1000) and DAPI (1:50 from 10 mg/L stock) in 1% BSA, 0.3% Triton-X in 0.1 M PB pH 7.4 for 2 h. After 3 washes in PBS for 15 min, sections were coverslipped with glycerol containing 2.5% DABCO. The vGluT polyclonal antibody has previously not been tested in lamprey but in rat and zebrafish. The target protein sequence of the antibody lies within a region that is conserved across all vGluT proteins (vGluT1, vGluT2, vGluT3) and matches that of L. fluviatilis vGluT (only one vGluT has been described) with the exception of one amino acid (sequence proprietary but made available to the authors with NDA by the manufacturer).
The TH polyclonal antibody raised in chick (Abcam, cat # ab76442) has previously not been tested in lamprey but in mouse, rat and human. The staining is very specific and matches that of the AB152 TH antibody raised in rabbit of which the application in lamprey is well documented (e.g., [15, 42, 43] ).
Microscopy
Imaging was performed on a Leica CLSM SP8 confocal microscope with a 20x water immersion lens (HC PL APO CSC 20x/0.75) using hybrid detectors (HyD) and LasX software. If necessary, tile scan images were taken. Imaging was performed in sequence sets where a maximum of two channels with good separation were imaged simultaneously to minimize crosstalk between channels.
Image Processing and Analysis
All image processing was done in ImageJ 1.51h. Individual channels were adjusted for brightness and contrast, and pseudo-colors assigned. Maximum Intensity projections of Z stack were performed for better visualization in 2D. Otherwise, no manipulation of the images has been performed. Cells with different transmitter phenotypes were counted across the SNc/VTA and CSF-c region using the Multi-Point Tool of ImageJ in z stacks of 20 mm slices. To ease the work with double and triple labeled channels, the ImageJ Source Code was modified (see section ''Data and Software Availability'' below for details). Final figures have been assembled with Adobe Illustrator CC 2015.
Extracellular Recordings
For extracellular recordings 5 animals were used. To allow for extracellular recordings in the optic tectum and striatum, we first transected the head of animals deeply anesthetized with MS-222 (100 mgL-1; Sigma), and then the dorsal skin and cartilage were removed to expose the brain and spinal cord. The viscera and all muscles were removed to avoid movements. The preparation was pinned down in a transparent cooling chamber continuously perfused with aCSF at 6-8 C. Recordings were performed using tungsten microelectrodes ($1-5 MU) connected to a 4-channel MA 102 amplifier and a MA 103 preamplifier (Elektroniklabor, Zoologie, University of Cologne). Signals were digitized at 20 kHz using pClamp (version 10.2) software. The SNc/VTA stimulation was performed by using borosilicate glass microcapillaries connected to a stimulus isolation unit (MI401). Both the striatum and the SNc/VTA were reached through the ventricle, as shown in Figures 3A and 3H .
To block glutamatergic activity in the striatum, the AMPA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 80 mM; Tocris, Bristol, UK), and the NMDA antagonist aminophosphonovalerate (APV; 100 mM; Tocris) were locally applied in the striatum by pressure injection through a micropipette fixed to a holder (containing Fast Green to aid visualization of the injection spread), which was attached to an Picospritzer-II Microinjection Dispense System (Parker, Hollis, NH, USA). The holder was connected to a MP-285 motorized micromanipulator connected to a rotary optical encoder (ROE-200) through a MPC-200 controller (Sutter Instruments, Novato, CA, USA), so that the position of the pipette could be monitored to ensure precise drug injections.
Whole-Cell Recordings
Whole-cell current-clamp recordings were performed in two different preparations that allowed us to record deep layer neurons in the optic tectum or striatum neurons, while stimulating the SNc/VTA. In both cases (N = 26), the entire brain was embedded in agar (4% in aCSF), and the agar block containing the brain was glued to a metal plate, quickly transferred to ice-cold aCSF and slices were cut using a vibrating microtome (Microm HM 650V; Thermo Scientific, Waltham, MA, USA). For tectal recordings, the angle was adjusted to get transverse-oblique slices ($50-700 mm) in such a way that the SNc/VTA together with its fibers projecting to tectum were maintained (see Figure 3H ), and deep layer tectal neurons were exposed. For recordings in the striatum, a thick slice ($2 mm) was obtained, keeping the SNc/VTA and exposing striatal neurons. To ensure the accuracy of the stimulation, a small injection of dextran amine-TMR (3 kDa; 12% in saline; Molecular Probes) was performed in the SNc/VTA before embedding the brain in agar, so that this region could be later visualized during the experiments under the fluorescent microscope. Afterward, the agar block was mounted in a submerged recording chamber.
Whole-cell current-clamp recordings were performed with patch pipettes made from borosilicate glass (Hilgenberg GmbH, Malsfeld, Germany) using a vertical puller (Model PP-830; Narishige, Tokyo, Japan). The resistance of recording pipettes was 7-10 MU when filled with an intracellular solution of the following composition (in mM): 130 potassium gluconate, 5 KCl, 10 phosphocreatine disodium salt, 10 HEPES, 4 Mg-ATP, 0.3 Na-GTP; (osmolarity 265-275 mOsmol). Bridge balance and pipette-capacitance compensation were adjusted for using a MultiClamp 700B patch amplifier and Digidata 1322 analog-to-digital converter under software control 'PClamp' (Molecular Devices). Perfusion of the preparation was performed with aCSF at 6-8 • .
Recordings were performed in current-clamp mode. The amplitudes of the current injections were scaled to each individual neuron input resistance. The current steps were kept constant to compare the number of APs and their parameters before and after SNc/VTA application. This was performed at a depolarized baseline ($-60 mV), to avoid false negatives due to the voltage dependent dopaminergic effects previously observed in both tectum and striatum [3, 11] . For this, the current clamp was monitored so that the voltage baseline could be kept constant throughout all the recordings.
Stimulation of the SNc/VTA afferents was performed with the same borosilicate glass microcapillaries used for patch clamp recordings, connected to a stimulus isolation unit (MI401; Zoological Institute, University of Cologne). The stimulation intensity was set to one to two times the threshold strength (typically 10-100 mA) to evoke PSPs.
To block glutamatergic activity in the striatum, the AMPA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 80 mM; Tocris, Bristol, UK), and the NMDA antagonist aminophosphonovalerate (APV; 100 mM; Tocris) were bath applied. The D1 receptor agonist SKF 81297 [(±)-6-Chloro-2,3,4,5-tetrahydro-1-phenyl-1H-3-benzazepine hydrobromide; 10 mM; Tocris, Bristol, UK], or the D2 receptor agonist quinpirole hydrochloride [(4aR-trans)-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H-pyrazolo[3,4-g]quinoline hydrochloride; 20 mM; Tocris] were also bath applied. Application of either the D1 or the D2 receptor agonist was chosen depending on whether an enhancement or a decrease in excitability was observed after SNc/VTA tetanic stimulation.
QUANTIFICATION AND STATISTICAL ANALYSIS
Where applicable the number of animals (N) and the number of experiments performed or cells found (n) are indicated in the main text and the STAR Methods.
Estimation of Total Lamprey Brain Neurons
The total number of brain neurons of the lamprey (N = 4) was estimated by i) employing the isotropic fractionator method [44] to count all lamprey brain cells (6.97+/À0.3x10 5 ), ii) extrapolating the glia/neuron ratio to brain mass dependency from a variety of other species [45] to the lamprey resulting in an estimated glia to neuron ratio of 18% in the lamprey and, iii) calculating the total number of neurons by combining i+ii. Given that the glial/neuronal index is not known in the lamprey, the calculated number should be considered as an approximation. The detailed procedure was as follows: After isolation, the brains were fixed by immersion in 4% freshly prepared PFA for 4 weeks. Brains (including the rhombencephalon, mesencephalon, diencephalon and telencephalon) were kept in dissociation solution (40 mM sodium citrate with 1% Triton X-100) for 12 h. The brains were then briefly dried with a paper towel, and their masses determined with a precision scale. Each brain was grinded individually in dissociation solution in a Tenbroeck glass homogenizer for approx. 15 min until no tissue fragments were visible. The nuclei suspension was collected in a 15 mL centrifuge tube. The Tenbroeck homogenizer piston and walls were washed at least 3 times with dissociation solution and the wash solution transferred to the tube to avoid loss of nuclei. DAPI (1:20 from 10 mg/L stock) was added, and nuclei spun down for 5 min in a microcentrifuge. After removal of the supernatant (which was checked to be perfectly clear and free of DAPI labeled nuclei) with a micropipette (without disturbing the pellet), PBS was added to complete the suspension volume to 1 mL, and the suspension was homogenized using the micropipette with Biozym SurPhob low binding tips. Four 10 mL samples were immediately collected and placed in different chambers of two hemocytometers (Marienfeld Neubauer improved), and nuclei were allowed 1-2 min to sink. The number of DAPI labeled nuclei was counted in a 1x1x0.1 mm volume of the hemocytometer, i.e., in 0.1mL for each sample. The number of DAPI labeled nuclei was averaged over all samples and using the total suspension volume and the count volume the total number of cells c total was calculated (6.97+/À0.3x10 5 ). According to Figure 1B in [45] , and using the lamprey brain mass of 21+/À2 mg as determined from the 4 brains used for cell counting, the glia to neuron ratio (gtoN) in the lamprey was estimated to be gtoN = 0.47x(21 0.245 ) = 18%, whereby the factor 0.47 has been extracted from the above cited figure. Finally, the total neuron number n total was approximated by n total = c total / (gtoN + 1) = 6.97x10 5 / (0.18+1) = 5.9x10 5 .
Characterization of SNc/VTA neurons
For determining the total number of SNc/VTA dopaminergic neurons, every other section (20 mm/section) was counted (N = 3). For counting all neurotransmitter phenotypes, three sections were counted: a rostral, an intermediate and a more caudal SNc/VTA section. For each channel (DAPI, TH, GAD, vGluT, Neurobiotin, dextran amine-TMR), labeled cells were counted independently. Only those cells that displayed a clear DAPI labeling of the cell nucleus were considered (a z-position match was verified in the z stack). Subsequently, markers of multiply labeled cells were replaced with specific markers for the specific multi-labeled phenotype until each cell was labeled by a single marker only. This labeling procedure was carried out independently by two persons experienced in cell counting. Then, the polygon ROI tool was used to mark the different regions (SNc/VTA, CSF-c) and a custom written bean shell script based on [46] was used to extract the count of cells with specific phenotype for each region, and to export the results to a spreadsheet (see section ''Data and Software Availability'' below for details). Using LibreOffice Calc, the cell count data of individual sections and persons were merged and analyzed. First, the counts performed by two persons were averaged, and then the numbers for left and right hemispheres were pooled. For the count of all dopaminergic SNc/VTA neurons, the Abercrombie correction factor was applied as follows: N = n Ã T=ðT + HÞ = n Ã 0:69; whereby N is the corrected cell number, n the raw count of cells, T the section thickness (here 20mm), and H the average height of the cell nuclei perpendicular to the section (here estimated to be 9mm). Since the section height exceeds the nuclei height by a factor larger than two, the error is negligible [47] . Therefore, a correction factor of 0.69 was applied.
To compare cell sizes of dopaminergic cells between SNc/VTA and CSF-c, up to 20 cells (depending on availability) of each phenotype were measured in each subregion, and each of the three sections for which all phenotypes were counted. As a first step, an ellipse was manually fit to each cell considered for size measurement using TH protein and/or vGluT and/or GAD mRNA as indicators of cell body extent. Ellipses for all cells of a specific phenotype in a specific region were added to the ImageJ Roi-Manager and finally relevant data was exported as a spreadsheet file. The minor diameter of the ellipse was then taken as a measure of cell size.
Electrophysiological Analysis
The dopaminergic effects of the SNc/VTA tetanic stimulation on neuronal excitability in the optic tectum and striatum were evaluated by comparing the number of APs for the same ramp of depolarizing current injections. To analyze the effects of blocking glutamatergic transmission, we measured from the baseline the amplitude of the EPSPs evoked after SNc/VTA stimulation before, and after APV and CNQX application. For statistical analysis, we used two-sample paired t tests (Wilcoxon signed-rank test) in MATLAB. To compare the size of neurons in the SNc/VTA with the size of neurons in the mammillary area, we used Student's t test, two-tailed, two samples, unequal variance (heteroscedastic). Throughout the figures, statistical significance is shown as follows: *p < 0.05, **p < 0.01, ***p < 0.001. e5 Current Biology 29, 677-685.e1-e6, February 18, 2019
DATA AND SOFTWARE AVAILABILITY
Two extensions have been added to ImageJ:
To ease the work with double and triple labeled channels, the ImageJ Source Code was modified to improve usability including quick switching between different counters, modification of colors, fine-tuned point visibility (restriction to a subset of counters and/or slices of the z stack), save and restore functionality via the ROI-Manager and Export of counter data -source code is available on request but will also be send in as a patch to ImageJ.
To export counts of multiple counters separated by region to a spreadsheet file, a custom beanshell script was written based on [46] . Source code is available on request but will also be sent in with the multi point counter patch described above.
